[Current aspects of agranulocytosis (15 cases)].
D000082:Acetaminophen / Q000009:adverse effects; D000328:Adult; D000368:Aged; D000380:Agranulocytosis / Q000139:chemically induced* / Q000473:pathology; D000404:Ajmaline / Q000009:adverse effects; D000632:Aminopyrine / Q000009:adverse effects; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001772:Blood Cell Count; D001854:Bone Marrow Cells; D002701:Chloramphenicol / Q000009:adverse effects; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia; D008213:Lymphocyte Activation; D008875:Middle Aged; D010615:Phenacetin / Q000009:adverse effects; D000637:Transaminases / Q000097:blood
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000632:Aminopyrine; D000404:Ajmaline; D000082:Acetaminophen; D002701:Chloramphenicol; D000637:Transaminases; D010615:Phenacetin
Aspects actuels de l'agranulocytose (a propos de 15 observations)